ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

NCI to Undergo More GAO Probes

July 15, 1977

St. Jude Offers Three Fellowships

March 2, 1984

In Brief: JNCI Article Describes Advances Pancreatic Cancer; Preventative Oncology Society Formed

August 13, 1976

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010